7,016 Merit Medical Systems, Inc. $MMSI Shares Sold by State of Alaska Department of Revenue

Posted by Brian Himes on Oct 21st, 2026

State of Alaska Department of Revenue lowered its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) by 35.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 12,630 shares of the medical instruments supplier’s stock after selling 7,016 shares during the quarter. State of Alaska Department of Revenue’s holdings in Merit Medical Systems were worth $1,088,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. AMI Asset Management Corp lifted its position in Merit Medical Systems by 0.8% in the first quarter. AMI Asset Management Corp now owns 21,818 shares of the medical instruments supplier’s stock worth $1,504,000 after buying an additional 168 shares during the last quarter. Arizona State Retirement System boosted its stake in Merit Medical Systems by 1.1% during the second quarter. Arizona State Retirement System now owns 16,459 shares of the medical instruments supplier’s stock worth $1,141,000 after buying an additional 174 shares during the period. EverSource Wealth Advisors LLC increased its position in Merit Medical Systems by 16.2% during the first quarter. EverSource Wealth Advisors LLC now owns 1,551 shares of the medical instruments supplier’s stock valued at $107,000 after acquiring an additional 216 shares during the last quarter. Farther Finance Advisors LLC increased its position in Merit Medical Systems by 44.0% during the third quarter. Farther Finance Advisors LLC now owns 890 shares of the medical instruments supplier’s stock valued at $77,000 after acquiring an additional 272 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Merit Medical Systems by 9.2% during the third quarter. GAMMA Investing LLC now owns 3,550 shares of the medical instruments supplier’s stock valued at $306,000 after acquiring an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Price Performance

MMSI opened at $91.18 on Wednesday. The business has a fifty day moving average of $88.30 and a 200 day moving average of $76.33. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $94.75. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The stock has a market cap of $5.44 billion, a P/E ratio of 37.68, a PEG ratio of 2.25 and a beta of 0.51.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The business’s revenue was up 9.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, sell-side analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on MMSI. BTIG Research reissued a “buy” rating and issued a $105.00 target price on shares of Merit Medical Systems in a research note on Tuesday, August 11th. Zacks Research raised shares of Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 25th. Piper Sandler upped their price target on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Wells Fargo & Company upped their price target on shares of Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Finally, Needham & Company LLC reissued a “buy” rating and issued a $101.00 price objective on shares of Merit Medical Systems in a research report on Tuesday, September 29th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $100.00.

Check Out Our Latest Analysis on Merit Medical Systems

About Merit Medical Systems

(Free Report)

Merit Medical Systems, Inc is a medical device company that develops, manufactures and distributes disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in hospitals, outpatient facilities and other clinical settings.

The company’s product portfolio includes devices for vascular access, angiography, intervention, drainage, embolization, oncology and cardiac procedures. Merit also offers products used in peripheral intervention, spine procedures and other specialized areas of minimally invasive medicine, including kits, accessories and related procedural equipment.

Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves healthcare providers through a global commercial and manufacturing network.